Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 6 - Number 2



Cyclooxygenase-2 Inhibitors: A Painful Lesson

, 6(2): 83 - 98

Sandhya Sanghi, Eric J. MacLaughlin, Coty W. Jewell, Sheldon Chaffer, Peter J. Naus, Linley E. Watson and David E. Dostal


DOI: 10.2174/187152906777441803





Uremia, Atherothrombosis and Malnutrition: The Role of L-arginine- Nitric Oxide Pathway

, 6(2): 131 - 138

Tatiana M.C. Brunini, Clarissa D. da Silva, Mariana A.S. Siqueira, Monique B. Moss, Sergio F. F. Santos and Antonio C. Mendes-Ribeiro


DOI: 10.2174/187152906777441821



Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Biography
View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

September Health DaysUnderstanding Research EthicsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog